寧波東力(002164.SZ):目前機器人關節精密減速器尚處於研發階段
格隆匯3月18日丨寧波東力(002164.SZ)公佈股票交易異常波動公告,目前機器人關節精密減速器尚處於研發階段,未產生相關產品及業績。(1)公司擬與重慶大學簽署《技術開發(合作)合同》,擬就機器人關節及對構齒輪技術應用開發項目展開合作。(2)公司擬籌劃設立一家合資公司,主要從事機器人關節精密減速器研發、製造、銷售等業務。公司將根據《深圳證券交易所股票上市規則》等法律法規嚴格執行審議程序,履行相關信息披露義務。公司設立還需按照規定辦理註冊登記手續,尚存在註冊設立覈準等風險。可能存在因宏觀經濟、行業環境、政策變化、經營管理等不確定因素帶來的風險。公司前期已採取相關措施將該信息的知情者控制在最小範圍內。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.